HomeCommentary

Commentary

With Study Group on Counterfeit Drugs to Resume Discussions this Fall, Full-Scale Discussions on Introduction of PIC/S GDP Guidelines Looming
(Oct.10.2017)

By Tomoyuki Iwasaki

The health ministry’s study group on counterfeit drugs will meet again this autumn. In its interim report announced in June, the study group noted that the establishment of domestic rules consistent with global PIC/S GDP guidelines on the distribution of ethical drugs is one of the remaining challenges. A separate study is being conducted with funding from the health ministry, so full-scale discussions on domestic rules consistent with the GDP guidelines appear to be on the horizon ...

(LOG IN FOR FULL STORY)

News Calendar